Clinical and genetic determinants of nevirapine plasma trough concentration.
Andrea GiacomelliStefano RusconiFelicia Stefania FalvellaMaria Letizia OreniDario CattaneoValeria CozziGiulia RenisiElisa MongeStefania CheliEmilio ClementiAgostino RivaMassimo GalliAnna Lisa RidolfoPublished in: SAGE open medicine (2018)
Our study, conducted in a prevalent Caucasian population, highlighted the importance of CYP2B6 genetic variants in influencing nevirapine plasma trough concentration. Furthermore, older age and hepatitis C virus coinfection significantly increase exposure to nevirapine.